Nasopharyngeal carcinoma (NPC) is closely associated with Epstein-Barr virus (EBV) and
occurs frequently in the south of China and Southeast Asian countries. Concurrent chemo …

Nasopharyngeal carcinoma (NPC) has seen improved treatment outcomes and a decrease
in incidence worldwide in recent years due to developments in medicine and improved …

Head and neck squamous cell carcinoma (HNSCC) is a molecularly heterogeneous
disease, with a 5-year survival rate that still hovers at~ 60% despite recent advancements …

Simple Summary Nasopharyngeal carcinoma is a serious major public health problem in its
endemic countries. Up to 80% of NPC patients with locally advanced disease or distant …

Nasopharyngeal carcinoma (NPC) is a squamous carcinoma with apparent geographical
and racial distribution, mostly prevalent in East and Southeast Asia, particularly …

Nasopharyngeal carcinoma (NPC) is a malignant tumor commonly associated with Epstein–
Barr virus (EBV) infection, and its early diagnosis as well as its differentiation from …

Purpose To establish and validate a nomogram to predict overall survival in locoregionally
advanced nasopharyngeal carcinoma (LA-NPC) based on inflammatory biomarkers and …

Abstract The Epstein–Barr virus (EBV) genome encodes a cluster of 22 viral microRNAs,
called miR‐BamHI‐A rightward transcripts (miR‐BARTs), which are shown to promote the …

Abstract Epstein‐Barr virus (EBV) BamHI A rightward transcripts (BART) encoded
microRNAs (EBV‐miR‐BARTs) are abnormally highly expressed in nasopharyngeal …

The identification of agents that can reverse drug resistance in cancer chemotherapy, and
enhance the overall efficacy is of great interest. Paclitaxel (PTX) belongs to taxane family …